NCT00637260

Brief Summary

Deep Brain Stimulation represents the golden standard for surgical treatment of Parkinson disease (PD), but it is not optimally effective for controlling every motor sign and adverse events are not so infrequent Therefore, other approaches should be considered.We identified the motor cortex as a possible candidate and therefore we propose a double-blind randomized prospective study in 20 Parkinson patients in order:

  • to test the efficacy of epidural motor cortex stimulation in Parkinson disease (primary endpoint: UPDRS III at 12 months at the end of the cross-over)
  • to find out optimal electrode position and optimal stimulation parameters

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2007

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 10, 2008

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 17, 2008

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
Last Updated

September 2, 2015

Status Verified

September 1, 2015

Enrollment Period

5.5 years

First QC Date

March 10, 2008

Last Update Submit

September 1, 2015

Conditions

Keywords

motorcortex stimulationParkinson's diseaseneuromodulation

Outcome Measures

Primary Outcomes (1)

  • UPDRS III

    12 months - end of crossover

Secondary Outcomes (5)

  • UPDRS III

    18, 30 and 31 months

  • UPDRS

    6,12, 18, 30, 31 months

  • Parkinson's disease quality of life scale(PDQL)

    6, 12, 18, 30, 31 months

  • Neuropsychological and mood evaluation

    6, 12, 18, 30 months

  • Drug therapy

    6, 12, 18, 30, 31 months

Study Arms (2)

A

EXPERIMENTAL
Device: Motor cortex stimulation on.

B

SHAM COMPARATOR
Device: motor cortex stimulation off

Interventions

The parameters of stimulation will be: contact 0 cathode, contact 3anode, 120microsec, 80 Hz, subthreshold for any movement or sensation, usually 3-5Volts. The stimulator will be switched on, continuously.

Also known as: Motor cortex stimulation on
A

The parameters of stimulation will be: contact 0 cathode, contact 3 anode, 120microsec, 80 Hz, subthreshold for any movement or sensation, usually 3-5 volts. The stimulator will be switched off.

B

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Idiopathic PD as diagnosed by a neurologist - a movement disorders specialist, according to the Parkinson Disease Brain Bank criteria, with asymmetrical bradykinesia, rigidity, tremor and postural instability (at least 3 from the above)
  • Significant clinical response to Levodopa (improvement of UPDRS motor score \> 20%).
  • Disease duration \> 5 years
  • Advanced stage of disease:
  • UPDRS motor score in off condition \>/= 40/108
  • Hoehn \& Yahr stage \>/= 3
  • DBS surgery not indicated or expressly refused by the patient
  • Antiparkinsonian therapy stable for at least one month prior to implant
  • Capability to give informed consent to surgery and to the study.

You may not qualify if:

  • Severe cognitive impairment or dementia
  • Psychiatric disturbances with the exception of mild anxiety or depression and drug-induced psychiatric symptoms (i.e. benign hallucinations)
  • History of epilepsy or documented electroencephalographic abnormalities suggesting epilepsy
  • Previous neurosurgery of the brain (DBS or lesioning of the basal ganglia, fetal tissue transplantation )
  • Lack of informed consent
  • History of drug or alcohol abuse
  • Poor general conditions increasing surgical risk or severe illness with poor prognosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Università Cattolica - Policlinico Gemelli - Neurochirurgia Funzionale

Roma, 00168, Italy

Location

Related Publications (3)

  • Cioni B. Motor cortex stimulation for Parkinson's disease. Acta Neurochir Suppl. 2007;97(Pt 2):233-8. doi: 10.1007/978-3-211-33081-4_26.

    PMID: 17691309BACKGROUND
  • Pagni CA, Altibrandi MG, Bentivoglio A, Caruso G, Cioni B, Fiorella C, Insola A, Lavano A, Maina R, Mazzone P, Signorelli CD, Sturiale C, Valzania F, Zeme S, Zenga F. Extradural motor cortex stimulation (EMCS) for Parkinson's disease. History and first results by the study group of the Italian neurosurgical society. Acta Neurochir Suppl. 2005;93:113-9. doi: 10.1007/3-211-27577-0_19.

    PMID: 15986739BACKGROUND
  • Cioni B, Meglio M, Perotti V, De Bonis P, Montano N. Neurophysiological aspects of chronic motor cortex stimulation. Neurophysiol Clin. 2007 Dec;37(6):441-7. doi: 10.1016/j.neucli.2007.10.007. Epub 2007 Nov 1.

    PMID: 18083500BACKGROUND

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Beatrice Cioni, MD

    Università Cattolica Roma, Italy

    PRINCIPAL INVESTIGATOR
  • Mario Meglio, Prof, MD

    Università Cattolica Roma, Italy

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

March 10, 2008

First Posted

March 17, 2008

Study Start

December 1, 2007

Primary Completion

June 1, 2013

Study Completion

June 1, 2013

Last Updated

September 2, 2015

Record last verified: 2015-09

Locations